Clinical Trials Browser

Phase 2 × testosterone undecanoate × Genitourinary × Clear all

NCT05081193 2025-09-22

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT03379012 2019-10-22

FARETES

Phase 2 Completed

Carcinoma, Renal Cell